Press Corner
Medesis Pharma Successfully Completes Phase I Clinical Trial of NP01
Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trial of NP01, a first in class anti-diabetic for the treatment of type 2 diabetes mellitus.
Press Release | 2010-05-31 | Read the full article
Letter to patients suffering from Huntington’s disease
NP03 in development for the treatment of Huntington’s disease
Letter to patients NP03 | 2009-12-11 | Read the full article
